"Generic versions of semaglutide (active ingredient in Ozempic) have launched in Canada, priced significantly lower than the brand name. Apotex and Dr. Reddy’s are among the first manufacturers to receive approval. Novo Nordisk is responding by offering discount programs for uninsured patients."